✉news HealthMedicine first seen 1 d ago, last 1 d ago, peak #37
Medicare Advantage Transplant Gap Clouds ESKD Trial Enrollment
Original: When Payer Status Becomes a Protocol Variable: What the Medicare Advantage Transplant Gap Means for ESKD Trial Enrollment
A new commentary examines how Medicare Advantage patients with end-stage kidney disease face lower access to kidney transplants, and argues that this payer-driven gap can distort clinical trial enrollment when payer status effectively becomes a hidden protocol variable. If trial populations skew toward traditional Medicare or commercial insurance, results may not generalize to Advantage beneficiaries. The piece is prompting discussion among nephrology researchers about equitable trial design.
Why now: Rising Medicare Advantage enrollment among kidney patients is raising fresh concerns about bias and equity in ESKD clinical research.
Medicare AdvantageESKDkidney transplantThe Clinical Trial Vanguard
Evidence
- When Payer Status Becomes a Protocol Variable: What the Medicare Advantage Transplant Gap Means for ESKD Trial Enrollment · The Clinical Trial Vanguard
API: https://socialmediatrends-api.osmike.com/v1/trends/3212634